Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9Z83
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,507
Award facts
- Contract value 100% obligated
- $12,507.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $12,507.18, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a contract to supply Ozempic 0.25-0.5 mg/dose pens in 3ml vials for the Defense Logistics Agency. The contract is firm fixed-price, non-set-aside, and carries an ultimate completion date of January 23, 2026. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026, which enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The Defense Logistics Agency's Medical Supply Chain relies on Amerisourcebergen Drug Corp as a critical vendor for pharmaceutical procurement supporting military and veteran healthcare systems. Ozempic, a diabetes medication included in this award, represents the type of specialty pharmaceutical product the company routinely delivers through its broad portfolio of competitively awarded contracts with DLA. The firm's extensive experience fulfilling federal medical procurement requirements across multiple therapeutic domains, combined with its established IDC vehicle, positions it to efficiently deliver this and similar pharmaceutical commodities to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9Z83?
SPE2DR26F9Z83 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9Z83 worth?
The government has obligated $12,507 on SPE2DR26F9Z83.
Is contract SPE2DR26F9Z83 an order under another contract?
Yes. SPE2DR26F9Z83 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Z83 competed?
The extent of competition for SPE2DR26F9Z83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award